ANI Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. 

CEO
Nikhil Lalwani
CEONikhil Lalwani
Employees
970
Employees970
Headquarters
Baudette, Minnesota
HeadquartersBaudette, Minnesota
Founded
1996
Founded1996
Employees
970
Employees970

ANIP Key Statistics

Market cap
1.75B
Market cap1.75B
Price-Earnings ratio
23.55
Price-Earnings ratio23.55
Dividend yield
Dividend yield
Average volume
413.93K
Average volume413.93K
High today
$78.91
High today$78.91
Low today
$77.60
Low today$77.60
Open price
$78.21
Open price$78.21
Volume
205.43K
Volume205.43K
52 Week high
$99.50
52 Week high$99.50
52 Week low
$56.71
52 Week low$56.71

Stock Snapshot

As of today, ANI Pharmaceuticals(ANIP) shares are valued at $78.26. The company's market cap stands at 1.75B, with a P/E ratio of 23.55.

As of 2026-04-15, ANI Pharmaceuticals(ANIP) stock has fluctuated between $77.60 and $78.91. The current price stands at $78.26, placing the stock +0.9% above today's low and -0.8% off the high.

The ANI Pharmaceuticals(ANIP)'s current trading volume is 205.43K, compared to an average daily volume of 413.93K.

In the last year, ANI Pharmaceuticals(ANIP) shares hit a 52-week high of $99.50 and a 52-week low of $56.71.

In the last year, ANI Pharmaceuticals(ANIP) shares hit a 52-week high of $99.50 and a 52-week low of $56.71.

ANIP News

Simply Wall St 6d
ANI Pharmaceuticals Expands Limited Competition Portfolio With New Cardiovascular Generic

ANI Pharmaceuticals, Inc. (NasdaqGM: ANIP) has launched Isosorbide Mononitrate Tablets following final FDA approval. The product adds a new limited competition...

ANI Pharmaceuticals Expands Limited Competition Portfolio With New Cardiovascular Generic
TipRanks 7d
ANI Pharmaceuticals launches Isosorbide Mononitrate Tablet USP

ANI Pharmaceuticals (ANIP) announced that following final approval from the FDA for its Abbreviated New Drug Application, or ANDA, the Company launched Isosorbi...

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ANIP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.